Hoedemaeker RF - Search Results

1

[Diagnosis based on prostate needle biopsy: inadequate correlation between pathologic results and clinical course for individual prognosis].

van der Kwast TH, Hoedemaeker RF, Schröder FH. van der Kwast TH, et al. Among authors: hoedemaeker rf. Ned Tijdschr Geneeskd. 2005 Apr 30;149(18):972-6. Ned Tijdschr Geneeskd. 2005. PMID: 15903037 Review. Dutch.

2

Detection rates of high-grade prostate cancer during subsequent screening visits. Results of the European Randomized Screening Study for Prostate Cancer.

van der Kwast TH, Ciatto S, Martikainen PM, Hoedemaeker R, Laurila M, Pihl CG, Hugosson J, Neetens I, Nelen V, Di Lollo S, Roobol MJ, Määtänen L, Santonja C, Moss S, Schröder FH. van der Kwast TH, et al. Int J Cancer. 2006 May 15;118(10):2538-42. doi: 10.1002/ijc.21667. Int J Cancer. 2006. PMID: 16353141 Clinical Trial.

3

Comparison of pathologic characteristics of T1c and non-T1c cancers detected in a population-based screening study, the European Randomized Study of Screening for Prostate Cancer.

Hoedemaeker RF, Rietbergen JB, Kranse R, van der Kwast TH, Schröder FH. Hoedemaeker RF, et al. World J Urol. 1997;15(6):339-45. doi: 10.1007/BF01300181. World J Urol. 1997. PMID: 9436283 Clinical Trial.

4

Comparison of prostate-specific antigen corrected for total prostate volume and transition zone volume in a population-based screening study.

Rietbergen JB, Kranse R, Hoedemaeker RF, Kruger AE, Bangma CH, Kirkels WJ, Schröder FH. Rietbergen JB, et al. Among authors: hoedemaeker rf. Urology. 1998 Aug;52(2):237-46. doi: 10.1016/s0090-4295(98)00138-1. Urology. 1998. PMID: 9697788 Clinical Trial.

5

Repeat screening for prostate cancer after 1-year followup in 984 biopsied men: clinical and pathological features of detected cancer.

Rietbergen JB, Kruger AE, Hoedemaeker RF, Bangma CH, Kirkels WJ, Schröder FH. Rietbergen JB, et al. Among authors: hoedemaeker rf. J Urol. 1998 Dec;160(6 Pt 1):2121-5. doi: 10.1097/00005392-199812010-00046. J Urol. 1998. PMID: 9817336 Clinical Trial.

6

Evaluation of prostate needle biopsies in a population-based screening study: the impact of borderline lesions.

Hoedemaeker RF, Kranse R, Rietbergen JB, Kruger AE, Schröder FH, van der Kwast TH. Hoedemaeker RF, et al. Cancer. 1999 Jan 1;85(1):145-52. Cancer. 1999. PMID: 9921986 Clinical Trial.

7

The changing pattern of prostate cancer at the time of diagnosis: characteristics of screen detected prostate cancer in a population based screening study.

Rietbergen JB, Hoedemaeker RF, Kruger AE, Kirkels WJ, Schröder FH. Rietbergen JB, et al. Among authors: hoedemaeker rf. J Urol. 1999 Apr;161(4):1192-8. J Urol. 1999. PMID: 10081868 Review.

8

Prostate cancer detection at low prostate specific antigen.

Schröder FH, van der Cruijsen-Koeter I, de Koning HJ, Vis AN, Hoedemaeker RF, Kranse R. Schröder FH, et al. Among authors: hoedemaeker rf. J Urol. 2000 Mar;163(3):806-12. J Urol. 2000. PMID: 10687982 Clinical Trial.

9

Histopathological prostate cancer characteristics at radical prostatectomy after population based screening.

Hoedemaeker RF, Rietbergen JB, Kranse R, Schröder FH, van der Kwast TH. Hoedemaeker RF, et al. J Urol. 2000 Aug;164(2):411-5. J Urol. 2000. PMID: 10893598 Clinical Trial.

10

Staging prostate cancer.

Hoedemaeker RF, Vis AN, Van Der Kwast TH. Hoedemaeker RF, et al. Microsc Res Tech. 2000 Dec 1;51(5):423-9. doi: 10.1002/1097-0029(20001201)51:5<423::AID-JEMT4>3.0.CO;2-4. Microsc Res Tech. 2000. PMID: 11074612 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

43 results

Search Page

Filters